




March spotlight: gender equity
Join the journey to gender-inclusive health care
Gender equity in health care is essential for communities to truly thrive, but it is often overlooked in public policy and program development.
PATH advocates for gender equity in public health policy to ensure fair compensation and equitable access to resources for all genders. We are also increasing access to gender-inclusive services, and creating innovative technologies to improve better health for all.
Make a gift to PATH today and help us advance gender-inclusive health care around the world.
Public health across sectors
We forge partnerships across sectors and borders, with governments and philanthropists, nonprofits and the private sector. We’ve been doing it for more than 40 years.
Focused on equity
Everyone deserves the chance to live a healthy life. With the help of our partners, we develop, adapt, and scale up solutions to accelerate progress toward health equity.
We are committed to diversity, equity, and inclusion
Our mission hinges on a strong commitment to diversity, equity, and inclusion –within our teams, and in our work.
We work on vaccines, drugs, medical devices, diagnostics, digital tools, and innovative approaches to strengthening health systems. Our team includes scientists, epidemiologists, market analysts, engineers, advocates, and experts from dozens of other specialties. Together, we develop, introduce, and scale up solutions to the world’s most pressing public health challenges.
The scope of our work is vast because it must be. Billions of people are still underserved or marginalized by inequitable systems. To close the gaps, we advance progress in dozens of health areas, from epidemic preparedness, HIV/AIDS, and malaria, to maternal and newborn care, sexual and reproductive health, tuberculosis, and more.
From Zambia to Vietnam and Kenya to India, we partner with local, national, and global decision-makers in more than 70 countries to shape evidence-based policies, make better use of data, navigate regulatory hurdles, shape markets for products that improve health, and design cost-effective systems to deliver these innovations to people who need them most.